NCT03565159 - Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors | Biotech Hunter

Enrollment

214

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Sepsis

Interventions

BIOLOGICAL

Prevenar 13

Pneumococcal polysaccharide conjugate vaccine

OTHER

Sodium Chloride 0.9%

Placebo

Trial Locations (12)

Unknown

Belfast Health and Social Care Trust, Belfast

CB2 2QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

EH16 4SA

NHS Lothian, Edinburgh

GU2 7XX

Royal Surrey County Hospital NHS Foundation Trust, Guildford

NW1 2BU

University College London Hospitals NHS Foundation Trust, London

SE1 7EH

Guy's and St Thomas' NHS Foundation Trust, London

SE5 9RS

King's College Hospital NHS Foundation Trust, London

M13 9WL

Manchester University NHS Foundation Trust, Manchester

NP20 2EF

Aneurin Bevan University Health Board, Newport

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

PO6 3LY

Portsmouth Hospitals NHS Trust, Portsmouth

SR4 7TP

South Tyneside and Sunderland NHS Foundation Trust, Sunderland

All Listed Sponsors

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER